PRODUCT CORPORATION TOTAL RETAIL DOLLARS(add 000)
Zoloft Pfizer 2,622,801
Effexor Wyeth 2,281,014
Zyprexa Eli Lilly 1,881,354
Lexapro Forest Labs 1,551,230
Risperdal Johnson & Johnson 1,436,891
Seroquel AstraZeneca 1,378,038
Wellbutrin GlaxoSmithKline 948,683
Celexa Forest Labs 856,665
Paxil GlaxoSmithKline 824,433
Abilify Bristol-Myers Squibb 747,400
Source: I manually compiled this list by using various websites. Some of which are:
Drug Topics
Rx List
PharmaLive
Search criteria:
"ten top selling" drugs US
"top OR best selling drugs" US 2005
"top * prescription drugs"
"top OR best selling" drugs "mental health"
best-selling "mental health drugs"
I hope the information provided is helpful.
Best regards,
Rainbow
Request for Answer Clarification by santabarbara-ga on 14 Oct 2005 14:12 PDT
Prozac aka Fluoxetine is not on the list?
Clarification of Answer by rainbow-ga on 14 Oct 2005 23:56 PDT
Thank you for the rating and generous tip.
Prozac (aka Fluoxetine) is number 156 on the list of the top 200
brand-name drugs by retail dollars in 2004.
Best regards,
Rainbow
santabarbara-ga rated this answer: and gave an additional tip of: $10.00
Very good answer. Thanks.
Comments
Subject: Re: Top 10 Best Selling Drugs
From: pforcelli-ga on 14 Oct 2005 15:03 PDT
Not terribly suprising that fluoxetine has dropped from the list,
considering the newer SSRIs (ie Zoloft aka Sertraline) have lower
occurance and less severe side effects.
Furthmore, drugs such as buproprion (welbutrin) are making inroads
into territory formerly solidly locked up by the SSRIs.
Subject: Re: Top 10 Best Selling Drugs
From: pforcelli-ga on 14 Oct 2005 15:05 PDT
Oh, as a side note, Fluox is off patent now, so perhaps this decreases
the percieved drug sale, due to multiple manufacturers (instead of
lily) distributing the drug - it still might be really highly used,
just not all sales coming from lily.
Subject: Re: Top 10 Best Selling Drugs
From: nhopper-ga on 17 Oct 2005 00:35 PDT
I think part of the popularity of buproprion is its use in nicotine
cessation in conjunction with the mood altering effects. There's a
pretty curious link between nicotine use and mental disorders. I'm not
sure if it's a statistically significant link, since I'm just
theorizing myself, but I think that compared to the general
population, people with major depressive disorder or dysthymia also
tend to use nicotine products at a higher rate. If you can treat both
simultaneously, bonus.
But also, there's no difference between Wellbutrin and Zyban. Zyban
costs more. And it's FDA approved for smoking cessation. Wellbutrin,
despite being an IDENTICAL substance, is not. A smart client and smart
doctor will save money by using buproprion instead of Zyban. It will
reflect as a Wellbutrin sale, however.
Top 10 Best Selling Drugs
Subject: Re: Top 10 Best Selling Drugs
Answered By: rainbow-ga on 14 Oct 2005 09:15 PDT
Rated:
Hi santabarbara,
The following is the result of my research for the data you have
requested on best selling drugs:
A List of the Best-Selling Drugs in the U.S.
(As appeared in the online version of the New York Times 9/30/04)
The top selling drugs in the United States in 2003, their annual
sales, what it treats and its manufacturer. The 2003 data is the most
recent audited figures available.
DRUG ANNUAL SALES TREATS MANUFACTURER
Lipitor $6.8 billion cholesterol Pfizer Inc.
Zocor $4.4 billion cholesterol Merck & Co.
Prevacid $4.0 billion heartburn TAP Pharma
Procrit $3.3 billion anemia Johnson & Johnson
Zyprexa $3.2 billion mental illness Eli Lilly & Co.
Epogen $3.1 billion anemia Amgen
Nexium $3.1 billion heartburn Merck & Co.
Zoloft $2.9 billion depression Pfizer Inc.
Celebrex $2.6 billion arthritis Pfizer Inc.
Neurontin $2.4 billion epilepsy Pfizer Inc.
Advair Diskus $2.3 billion asthma GlaxoSmithKline PLC
Plavix $2.2 billion blood clots Bristol-Myers Squibb
Norvasc $2.2 billion hypertension Pfizer Inc.
Effexor XR $2.1 billion depression Wyeth
Pravachol $2.0 billion cholesterol Bristol-Myers Squibb
Risperdal $2.0 billion mental illness Johnson & Johnson
Oxycontin $1.9 billion pain Perdue Pharma
Fosamax $1.8 billion osteoporosis Merck & Co.
Protonix $1.8 billion gastrointestinal Wyeth
Vioxx $1.8 billion arthritis Merck & Co.
Friedman & Simon
Top 200 Drugs for 2004 by U.S. Sales
"The information contained in this report was derived using NDCHealth
proprietary methodologies and is based on prescription data and
wholesale acquisition cost (WAC) prices for retail, mail order,
clinics, hospitals, long-term care and home health care organizations
and other non-retail channels."